CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation.

Kuehnle, I; Huls, M H; Liu, Z; Semmelmann, M; Krance, R A; Brenner, M K; Rooney, C M; Heslop, H E

Kuehnle, I; Huls, M H; Liu, Z; Semmelmann, M; Krance, R A; Brenner, M K; Rooney, C M; Heslop, H E.

Affiliation

Kuehnle I; Center for Cell and Gene Therapy and Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas 77030, USA.

Blood ; 95(4): 1502-5, 2000 Feb 15.

Article in En | MEDLINE | ID: mdl-10666232

Subject(s)

Antibodies, Monoclonal/therapeutic use; Antineoplastic Agents/therapeutic use; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/therapy; Leukemia, Myeloid, Acute/therapy; Lymphoma/therapy; Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy; Adolescent; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20/immunology; Bone Marrow Transplantation; Child, Preschool; Disease-Free Survival; Herpesvirus 4, Human/isolation & purification; Humans; Immunophenotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy; Leukemia, Myeloid, Acute/drug therapy; Lymphocytes/immunology; Lymphoma/drug therapy; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy; Rituximab; Time Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Leukemia, Myeloid, Acute / Herpesvirus 4, Human / Hematopoietic Stem Cell Transplantation / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Lymphoma / Antibodies, Monoclonal / Antineoplastic Agents Limits: Adolescent / Child, preschool / Humans / Male Language: En Journal: Blood Year: 2000 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links